Medwatch - Lantus (Insulin Glargine): FDA Reviewing Safety Data Re: Possible Risk

Lantus (insulin glargine) Audience - Diabetes healthcare professionals, patients ROCKVILLE, Md., July 1, 2009--FDA notified healthcare professionals and patients that it is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible risk fo...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Focusing on Fort Hood Killers Beliefs Are an Easy Out to Avoid the Deeper Reasons - Bulatlat.com

Palestinian uncle says Fort Hood suspect loved US, but work as psychiatrist drove - Metronews

G20 vows to spur fragile growth - BBC

Tory hostility to EU extradition law 'risks new Costa del Crime' - Observer

Family shock at Briton's bar murder A British father on a road-trip through the - Wharfvalley

Featured Members

Matthew Clark
Mentor
Entrepreneur

Niladri Roy
Manager-International Marketing
Computer Services

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map